Trulieve CEO Sells $1.2 Million in Stock as Shares Jump 148% in One Year

Impact · against what's priced in

Trulieve's approval to list on the NYSE and its transition to positive net income provide strong catalysts for institutional adoption and valuation re-rating. While the CEO's $1.2 million stock sale is a technical negative, it is negligible relative to the company's scale and recent 148% rally.

TRLV+0.60: No priced-in read yet
In context: The approval to list on the NYSE following Schedule III rescheduling fundamentally changes institutional accessibility and liquidity. This, combined with the company's first positive net income of $2 million and $100 million in adjusted EBITDA, marks a shift toward scalable profitability.
Read from the article alone

Trulieve CEO Sells $1.2 Million in Stock as Shares Jump 148% in One Year

TRLV
cannabis
insider selling
medical marijuana
mso
nyse listing
schedule iii
sec filing

Search tags

Trulieve CEO Sells $1.2 Million in Stock as Shares Jump 148% in One Year

What matters in this story

Synaptics' Key Insider Rahul Patel Sells Shares

Trulieve CEO Sells $1.2 Million in Stock as Shares Jump 148% in One Year

What matters in this story

Synaptics' Key Insider Rahul Patel Sells Shares

How each ticker is affected

Track these names every morning.

Curaleaf Relocates Gettysburg Dispensary to York, Bringing Care Closer to Patients in South Central Pennsylvania

Curaleaf Continues Florida Expansion with Wellington Dispensary Opening

Aurora Cannabis Announces the Alberta Securities Commission has dismissed Curaleaf's Application and ruled in favour of the Company's At-the-Market Program

Tilray Now Sells More Beer Than Cannabis. Here's Why That Might Be Good News for Investors.

Trulieve CEO Sells $1.2 Million in Stock as Shares Jump 148% in One Year

What matters in this story

Next reads from the same story arc

Synaptics' Key Insider Rahul Patel Sells Shares

Trulieve CEO Sells $1.2 Million in Stock as Shares Jump 148% in One Year

What matters in this story

Next reads from the same story arc

Synaptics' Key Insider Rahul Patel Sells Shares

How each ticker is affected

Track these names every morning.

Curaleaf Relocates Gettysburg Dispensary to York, Bringing Care Closer to Patients in South Central Pennsylvania

Curaleaf Continues Florida Expansion with Wellington Dispensary Opening

Aurora Cannabis Announces the Alberta Securities Commission has dismissed Curaleaf's Application and ruled in favour of the Company's At-the-Market Program

Tilray Now Sells More Beer Than Cannabis. Here's Why That Might Be Good News for Investors.